Sign in
4

Changes in Ownership

Q/C TECHNOLOGIES, INC. Filed Acc 0001683168-25-008517

Options or other derivatives

  • 10% owner bought 1,779,730 shares

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
PharmaCyte Biotech, Inc. 10% owner 2025-09-04 Purchase · Series H Convertible Preferred Stock +889,865 889,865 D
PharmaCyte Biotech, Inc. 10% owner 2025-11-14 Purchase · Warrants +889,865 889,865 D
Loading xslF345X05/ownership.xml…